Aberrantly methylated RUNX3 was found to be associated with the risk of multiple cancers, such as hepatocellular carcinoma [43], esophageal cancer [43], gastric carcinoma [44] and NSCLC [44]. The gene discussed is RUNX3; the disease is esophageal cancer.